Results 161 to 170 of about 630,791 (206)

Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age. [PDF]

Vaccines (Basel)
Omole T, Pelayo E, Weinberg AS, Chalkias S, Endale Z, Tamms G, Sterling TM, Good L, Shekar T, Johnson M, Banniettis N, Buchwald UK, Esteves-Jaramillo A.   +12 more
europepmc   +1 more source

Concentration and High Avidity of Pneumococcal Antibodies Persist at Least 4 Years after Immunization with Pneumococcal Conjugate Vaccine in Infancy [PDF]

, 2013
Nina Ekström, Heidi Åhman, Arto A. Palmu, Sinikka Grönholm, Terhi Kilpi, Helena Käyhty   +5 more
openalex   +1 more source

Review: current and new generation pneumococcal vaccines.

Journal of Infection, 2014
C. Feldman, R. Anderson
semanticscholar   +1 more source

Impact of influenza and pneumococcal vaccines on HIV persistence and immune dynamics during suppressive antiretroviral therapy. [PDF]

AIDS
Gianella S, Anderson C, Chaillon A, Wells A, Porrachia M, Caballero G, Meneses M, Lonergan J, Woodworth B, Gaitan NC, Rawlings SA, Muttera L, Harkness L, Little SJ, May S, Smith D.   +15 more
europepmc   +1 more source

Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A. [PDF]

, 1994
Solomon Langermann, Susan Palaszynski, Jeanne E. Burlein, Scott Koenig, Mark S. Hanson, David E. Briles, C. Kendall Stover   +6 more
openalex   +1 more source

Impact of Widespread Introduction of Pneumococcal Conjugate Vaccines on Pneumococcal and Nonpneumococcal Otitis Media.

Clinical Infectious Diseases, 2016
S. Ben-Shimol, N. Givon‐Lavi, E. Leibovitz, S. Raiz, D. Greenberg, R. Dagan   +5 more
semanticscholar   +1 more source

Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018-21. [PDF]

J Antimicrob Chemother
Schellenberg JJ, Adam HJ, Baxter MR, Karlowsky JA, Golden AR, Martin I, Zhanel GG.   +6 more
europepmc   +1 more source

Limited protection of pneumococcal vaccines against emergent Streptococcus pneumoniae serotype 14/ST876 strains. [PDF]

Infection
Lan Y, Liu L, Hu D, Ge L, Xiang X, Peng M, Fu Y, Wang Y, Li S, Chen Y, Jiang Y, Tu Y, Vidal JE, Yu Y, Chen Z, Wu X.   +15 more
europepmc   +1 more source

Hospitalizations for lower respiratory tract infections in children in relation to the sequential use of three pneumococcal vaccines in Quebec. [PDF]

Can J Public Health, 2020
Zhou Z, Gilca R, Deceuninck G, Boucher F, De Wals P.   +4 more
europepmc   +1 more source

FACTS AND OPINIONS ON USEFULNESS OF PNEUMOCOCCAL VACCINE

, 2009
М. П. Костинов, О. О. Магаршак, E.G. Belonogova   +2 more
openalex   +1 more source